Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT)
Withdrawn
- Conditions
- Breast Cancer
- Interventions
- Radiation: Radiation Therapy
- Registration Number
- NCT04917640
- Lead Sponsor
- GenesisCare USA
- Brief Summary
This is a registry study that will be used to evaluate external beam radiation therapy methods for the accelerated treatment of breast cancer. Patients are being asked to take part in this registry because they have breast cancer and desire treatment with accelerated partial breast irradiation to be delivered by external beam methods.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- Greater than or equal to 50 years old Low to intermediate DCIS Tumor size < or = to 2cm
Exclusion Criteria
- BRCA positive Lobular histology Angiolymphatic invasion
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description SBRT Radiation Therapy Patients treated with Stereotactic Body Radiation Therapy (SBRT) IMRT Radiation Therapy Patients treated with Intensity Modulated Radiation Therapy (IMRT)
- Primary Outcome Measures
Name Time Method Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0". Through study completion, an average of 12 months Toxicity will be assessed using the CTCAEv4.0 and recorded.
- Secondary Outcome Measures
Name Time Method Number of participants with ipsilateral breast recurrence Through study completion, an average of 12 months Number of participants with pathologically confirmed ipsilateral breast recurrence.
Trial Locations
- Locations (1)
GenesisCare USA
馃嚭馃嚫Stuart, Florida, United States